USPTO serial 98480470
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Songpa-gu, Seoul, KR
Songpa-gu, Seoul, KR
Songpa-gu, Seoul, KR
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Max Vern
Max Vern AMSTER, ROTHSTEIN & EBENSTEIN LLP405 Lexington AvenueNew York, NY 10174United States| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances for the prevention of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; diagnostic agents for pharmaceutical use; diagnostic preparations for medical purposes; medical diagnostic test strips for blood analysis; diagnostic reagents for use in diagnostic tests for medical purposes; medical diagnostic reagents; chemical diagnostic reagents for medical use; in vitro diagnostic preparations for medical purposes for detecting cancer; indicators for medical diagnosis, namely, medical diagnostic reagents; reactants for medical diagnosis, namely, medical diagnostic reagents; pharmaceutical preparations for animals and humans for the treatment of cancer; pharmaceutical preparations for diagnosis of cancer; anti-cancer preparations | ACTIVE | — |
| 010 | Apparatus for the treatment of cancer; medical measuring instruments for measuring tumors for cancer diagnosis; medical instruments, namely, biopsy instruments; medical apparatus for detecting cancer; diagnostic measuring apparatus for medical use, namely, medical diagnostic apparatus for analyzing and measuring tumors in the body; apparatus for carrying-out diagnostic tests for testing for cancers for medical purposes; diagnostic apparatus for medical purposes for testing cancers; apparatus for blood analysis for medical use; apparatus for blood monitoring for medical use; medical diagnostic apparatus for detecting cancer for use in the fields of clinical diagnosis; diagnostic, examination, and monitoring equipment in the nature of medical diagnostic apparatus for detecting cancer; testing instruments for medical diagnostic purposes, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; automatic analyzers for medical diagnosis for analyzing circulating tumor DNA; tools for medical diagnostics in the nature of medical diagnostic apparatus for detecting cancer; medical examination sheets in the nature of medical table sheets for examining tables and operating tables; apparatus for clinical diagnosis; diagnostic apparatus and instruments for medical purposes in the nature of medical diagnostic apparatus for detecting cancer; blood analysis apparatus for medical diagnosis purposes; in vitro diagnostic devices for medical purposes in the nature of medical diagnostic apparatus for detecting cancer | ACTIVE | — |
| 035 | Wholesale store services featuring medical measuring instruments for cancer diagnosis; retail store services featuring medical measuring instruments for cancer diagnosis; wholesale store services featuring medical instruments; retail store services featuring medical instruments; retail store services featuring diagnostic reagents for medicinal use; retail store services featuring medical diagnostic test strips; wholesale store services featuring medical diagnostic test strips; retail store services featuring reagents for use in diagnostic tests for medical purposes; wholesale store services featuring reagents for use in diagnostic tests for medical purposes; wholesale store services featuring diagnostic reagents for medicinal use; retail store services featuring testing instruments for medical diagnostic purposes; wholesale store services featuring testing instruments for medical diagnostic purposes; wholesale store services featuring pharmaceuticals; retail store services featuring pharmaceuticals; wholesale store services featuring pharmaceutical preparations for animals and humans; retail store services featuring pharmaceutical preparations for animals and humans; retail store services featuring apparatus for clinical diagnosis; wholesale store services featuring apparatus for clinical diagnosis; wholesale store services featuring blood analysis apparatus for diagnosis; retail store services featuring blood analysis apparatus for diagnosis | ACTIVE | — |
| 042 | Research and development of technology for biotechnology; biotechnology services, namely, consulting services in the field of biotechnology; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; development of pharmaceutical preparations and medicines; medical research laboratory services; medical research laboratory services for predicting disease; remote monitoring services for medical diagnostic devices; computer programming services for remote data management of medical diagnostic instruments; design of medical diagnostic apparatus and instruments; providing technological support services in the nature of troubleshooting in the nature of diagnosing problems with medical equipment regarding medical diagnostic instruments; providing computer software technical support services in the nature of diagnosing computer hardware and software problems in the field of medical diagnostics; computer programming services for remote control of medical diagnostic systems; engineering services in the medical technology field; blood testing for medical research purposes, not for medical diagnostic purposes; medical research; medical and scientific research, namely, conducting clinical trials for others; clinical trials; blood analysis services; blood analysis services for scientific research purposes | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 12, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 12, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 22, 2025 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Jul 18, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 20, 2025 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Feb 20, 2025 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Feb 18, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 24, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 24, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 18, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 26, 2024 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Oct 15, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 15, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 15, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 15, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 15, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 15, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 10, 2024 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Sep 10, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 2, 2024 | NWAP | NEW APPLICATION ENTERED | — |